Ubon Bio Ethanol Public Company Limited

As of June 30, 2026, Ubon Bio Ethanol Public Company Limited carries a market capitalization of 2.11B, placing it among publicly traded companies globally. Its enterprise value stands at 2.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Ubon Bio Ethanol Public Company Limited's next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2026, Ubon Bio Ethanol Public Company Limited has 3.91B shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.44, and the price-to-book ratio stands at 0.38.

As of June 30, 2026, Ubon Bio Ethanol Public Company Limited trades at an EV/EBITDA multiple of 5.91 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.51 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.38B versus a market cap of 2.11B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Ubon Bio Ethanol Public Company Limited maintains a current ratio of 3.90, meaning it holds 3.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.44, indicating elevated leverage, while an interest coverage ratio of 28.14 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Ubon Bio Ethanol Public Company Limited posted a negative return on equity (ROE) of -1.75, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.44, reflecting losses generated across the asset base. The company generates approximately 5.96M in revenue per employee across its workforce of 790.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.02 indicates how many times Ubon Bio Ethanol Public Company Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Ubon Bio Ethanol Public Company Limited recorded 38.84M in income tax expense. The company reported a pretax loss of -38.90M and -99.34M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Ubon Bio Ethanol Public Company Limited's stock has gained approximately 20.83% over the past 52 weeks. The 50-day moving average sits at 0.56, while the 200-day moving average is 0.56.

Over the twelve months ended June 30, 2026, Ubon Bio Ethanol Public Company Limited generated 4.71B in revenue and converted that into -99.34M in net income, yielding earnings per share of -0.02. EBITDA reached 403.15M, while operating income came in at -20.48M.

As of June 30, 2026, Ubon Bio Ethanol Public Company Limited holds 340.55M in cash and equivalents against 430.72M in total debt, resulting in a net debt position of 84.42M. Total book value stands at 5.61B, with working capital of 1.50B providing operational flexibility.

Ubon Bio Ethanol Public Company Limited produced 707.93M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -75.85M in capital expenditures, free cash flow totaled 632.08M - equivalent to 0.16 per share.

Over the twelve months ended June 30, 2026, Ubon Bio Ethanol Public Company Limited posted a gross margin of 12.36, reflecting its pricing power and cost economics. The operating margin of -0.43 and net profit margin of -2.11 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Ubon Bio Ethanol Public Company Limited paid dividends of 0.02 per share. The dividend payout ratio of -135.84 is negative because earnings are negative, so the dividend is being paid out of something other than profits, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 30.36, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 30.46, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Ubon Bio Ethanol Public Company Limited shareholders.

As of June 30, 2026, Ubon Bio Ethanol Public Company Limited has an Altman Z-Score of 2.57, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.